Improving HPV vaccination rates among Latino adolescents in health centers
Investigating Facilitator-driven, Multi-level Implementation Strategies in Federally Qualified Health Centers to Improve Provider Recommendation and HPV Vaccination Rates Among Latino/a Adolescents
This study is testing new ways to help healthcare providers encourage Latino teens to get the HPV vaccine in health centers that serve their communities.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 225 (estimated) |
| Ages | 11 Years to 17 Years |
| Sex | All |
| Sponsor | The University of Texas Health Science Center, Houston Academic / other |
| Locations | 1 site (Houston, Texas) |
| Trial ID | NCT06598475 on ClinicalTrials.gov |
What this trial studies
This study aims to enhance HPV vaccination rates among Latino adolescents by implementing facilitator-driven strategies in Federally Qualified Health Centers (FQHCs). It will assess the characteristics of providers and practices that influence the effectiveness of these strategies. The study will involve training healthcare providers and staff, measuring outcomes, and evaluating the sustainability of the implementation across nine clinical sites. The focus is on increasing provider recommendations for HPV vaccinations in practices with low initiation rates.
Who should consider this trial
Good fit: Ideal candidates for this study are adolescents aged 11-17 who are patients at FQHCs with a predominantly Latino patient population and low HPV vaccination rates.
Not a fit: Patients who are not part of the Latino demographic or those who are not seeking care at participating FQHCs may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could significantly increase HPV vaccination rates among Latino adolescents, leading to better health outcomes and reduced incidence of HPV-related diseases.
How similar studies have performed: Other studies have shown success with similar facilitator-driven approaches to improve vaccination rates, indicating potential for positive outcomes in this context.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * FQHC's with less than 60% HPV vaccine initiation rate for 11-12 year old adolescents overall at their practice sites * FQHC's that have family medicine and/or pediatric practices * a total adolescent patient population at least 50% Latino * be willing for Health Care Provider (HCP) and staff members to receive education, training, and support; complete standardized measurement, and agree to randomization. * Providers, aged 18 and over, employed at each FQHC (4 staff per practice) * Staff, aged 18 and over, employed at each FQHC (5 staff per practice) * Implementation team members (i.e., administrative designee, health care providers, immunization navigators, and other staff), aged 18 and over, employed at each FQHC (4 members per practice) * Parents (aged 18 and over) of patients ages 11-17 seeking care at each FQHC (25 per practice). Exclusion Criteria: -FQHCs that participated in the pilot study were excluded.
Where this trial is running
Houston, Texas
- The University of Texas Health Science Center at Houston — Houston, Texas, United States (Recruiting)
Study contacts
- Principal investigator: Daisy Y Morales Campos, PhD — The University of Texas Health Science Center, Houston
- Study coordinator: Daisy Y Morales-Campos, PhD
- Email: Daisy.Y.MoralesCampos@uth.tmc.edu
- Phone: (210) 276 9042
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.